Form 6-K Legend Biotech Corp For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Legend Biotech Corp. (LEGN) PT Raised to $86 at RBC Capital
May 14, 2024 6:11 AM EDTRBC Capital analyst Leonid Timashev raised the price target on Legend Biotech Corp. (NASDAQ: LEGN) to $86.00 (from $85.00) while maintaining a Outperform rating.
The analyst comments "This morning LEGN reported 1Q24 earnings and we had a chance to catch up with... More
